K-numberK250987
Device nameaprevo® posterior/transforaminal lumbar interbody fusion device
ApplicantCarlsmed, Inc.
Product codeMAX
Device classClass II
Decision dateJun 30, 2025
DecisionSubstantially Equivalent
Regulation888.3080
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The aprevo® posterior/transforaminal lumbar interbody fusion device is a patient-specific, additively manufactured titanium spinal implant designed to stabilize the lumbar spine and facilitate fusion. It is indicated for interbody fusion in skeletally mature patients with degenerative disc disease, disc herniation, spondylolisthesis, deformity, spinal stenosis, pseudarthrosis, or severe adult spinal deformity, and must be used with supplemental fixation systems and bone graft.

Technological characteristics

The device is manufactured from titanium alloy (Ti-6Al-4V ELI) per ASTM F3001 using additive manufacturing and incorporates patient-specific features with a bone graft aperture. Associated instruments are made from stainless steel per ASTM A564. The device is personalized based on patient radiological images to determine surgical correction plans and configurations.

Test standards cited

ASTM F2077 (static and dynamic axial compression and compression-shear testing), ASTM F2267 (engineering analysis of subsidence), ASTM F3001 (titanium alloy additive manufacturing), and ASTM A564 (stainless steel for instruments).

Substantial equivalence argument

The aprevo® posterior device is substantially equivalent because it shares the same intended use, operating principle, design, materials, biocompatibility, manufacturing approach, and sterility as the predicate devices (primarily K241332 aprevo® TLIF device and K241019 aprevo® TLIF-C). Non-clinical testing demonstrated equivalent mechanical performance through static/dynamic compression and subsidence analysis, and cadaveric validation confirmed the device performs as intended. The personalized geometry and posterior approach represent modifications to an established predicate design without changing the fundamental function or safety profile.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →